Teva Posts Strong Q210 Results

Leading generic drugmaker Teva has posted a strong set of financial results for Q210, with sales increasing by 11.76% to US$3.8bn from US$3.4bn in Q209. Operating profit figures for Q210 amounted to US$1.20bn, a 22.43% increase on the Q209 operating profit figure of US$981mn.

To read the full article, please choose one of the following options: